David R. Nalin, MD, served in the U.S. Public Health Service at the National Institutes of Health, assigned to the Cholera Research Laboratory in Dhaka, East Pakistan (now the ICDDRB, Bangladesh), where he led the development of modern oral rehydration therapy. He continued his research career at the Johns Hopkins Center for Medical Research as Assistant Professor of Medicine and Pathobiology at Johns Hopkins Medical School and School of Public Health, and later as Associate Professor at the University of Maryland and Director of the Pakistan Medical Research Center in Lahore, Pakistan. He later was Director of Clinical research at Merck Research Laboratories, where he led the clinical trials leading to the hepatitis A vaccine, and subsequently was Director of Vaccine Scientific Affairs at Merck Vaccine Division. While in South Asia, Dr. Nalin became captivated with local cultures. Realizing ancient sculptures were being scrapped for their metal and destroyed in ethnic conflicts, he became committed to preserving the visual arts of the region. Dr. Nalin’s substantial art collection includes works from India and Bangladesh and Tibet, Nepal, and China.